| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. | Clin Cancer Res | 2005 | 0.85 |
| 2 | In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor. | J Transl Med | 2010 | 0.75 |